Login / Signup

How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial.

Ilaria MottaMartina CusinatoAndrew J LudmanNathalie LachenalMatthew DoddMoe SoeTleubergen AbdrasulievRuzilya UsmanovaIlhomjon ButabekovTigay Zinaida NikolaevnaIrina LiverkoNargiza ParpievaRonelle MoodliarVarvara SolodovnikovaEmil KazounisBern-Thomas Nyang'waKatherine L FieldingCatherine Berry
Published in: Antimicrobial agents and chemotherapy (2024)
This study is registered with ClinicalTrials.gov as NCT02589782.
Keyphrases
  • mycobacterium tuberculosis
  • clinical trial
  • pulmonary tuberculosis
  • heart rate variability
  • emergency department
  • randomized controlled trial
  • study protocol
  • drug induced
  • double blind
  • hiv infected
  • adverse drug